These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31805176)

  • 21. The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort.
    Close S; Marshall-Gradisnik S; Byrnes J; Smith P; Nghiem S; Staines D
    Front Public Health; 2020; 8():420. PubMed ID: 32974259
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
    Baos S; Brigden A; Anderson E; Hollingworth W; Price S; Mills N; Beasant L; Gaunt D; Garfield K; Metcalfe C; Parslow R; Downing H; Kessler D; Macleod J; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    Trials; 2018 Feb; 19(1):136. PubMed ID: 29471861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE.
    Scheibenbogen C; Freitag H; Blanco J; Capelli E; Lacerda E; Authier J; Meeus M; Castro Marrero J; Nora-Krukle Z; Oltra E; Strand EB; Shikova E; Sekulic S; Murovska M
    J Transl Med; 2017 Jul; 15(1):162. PubMed ID: 28747192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ).
    Peo LC; Wiehler K; Paulick J; Gerrer K; Leone A; Viereck A; Haegele M; Stojanov S; Warlitz C; Augustin S; Alberer M; Hattesohl DBR; Froehlich L; Scheibenbogen C; Jason LA; Mihatsch LL; Pricoco R; Behrends U
    Eur J Pediatr; 2024 Mar; 183(3):1265-1276. PubMed ID: 38095713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connectivity Between Salience and Default Mode Networks and Subcortical Nodes Distinguishes Between Two Classes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Su J; Thapaliya K; Eaton-Fitch N; Marshall-Gradisnik S; Barnden L
    Brain Connect; 2023 Apr; 13(3):164-173. PubMed ID: 36352819
    [No Abstract]   [Full Text] [Related]  

  • 26. Myalgic Encephalomyelitis-Chronic Fatigue Syndrome Common Data Element item content analysis.
    Slavin MD; Bailey HM; Hickey EJ; Vasudevan A; Ledingham A; Tannenbaum L; Bateman L; Kaufman DL; Peterson DL; Ruhoy IS; Systrom DM; Felsenstein D; Kazis LE
    PLoS One; 2023; 18(9):e0291364. PubMed ID: 37698999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating unexplained fatigue in general practice with a particular focus on CFS/ME.
    Bansal AS
    BMC Fam Pract; 2016 Jul; 17():81. PubMed ID: 27436349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems in defining post-exertional malaise.
    Jason LA; Evans M; So S; Scott J; Brown A
    J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].
    Kuratsune H
    Brain Nerve; 2018 Jan; 70(1):11-18. PubMed ID: 29348370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Collatz A; Johnston SC; Staines DR; Marshall-Gradisnik SM
    Clin Ther; 2016 Jun; 38(6):1263-1271.e9. PubMed ID: 27229907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis.
    Maeda KI; Islam MF; Conroy KE; Jason L
    Psychol Health Med; 2023 Dec; 28(10):3052-3063. PubMed ID: 36977713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
    Haney E; Smith ME; McDonagh M; Pappas M; Daeges M; Wasson N; Nelson HD
    Ann Intern Med; 2015 Jun; 162(12):834-40. PubMed ID: 26075754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring Symptom Fluctuations and Triggers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Novel Patient-Centred N-of-1 Observational Designs: A Protocol for a Feasibility and Acceptability Study.
    McDonald S; Tan SX; Banu S; van Driel M; McGree JM; Mitchell G; Nikles J
    Patient; 2022 Mar; 15(2):197-206. PubMed ID: 34368926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing specialist medical care with specialist medical care plus the Lightning Process for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial).
    Crawley E; Mills N; Hollingworth W; Deans Z; Sterne JA; Donovan JL; Beasant L; Montgomery A
    Trials; 2013 Dec; 14():444. PubMed ID: 24370208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study.
    Castro-Marrero J; Faro M; Aliste L; Sáez-Francàs N; Calvo N; Martínez-Martínez A; de Sevilla TF; Alegre J
    Psychosomatics; 2017; 58(5):533-543. PubMed ID: 28596045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Turning a Corner in ME/CFS Research.
    Pheby DFH; Friedman KJ; Murovska M; Zalewski P
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
    Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
    J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Lim EJ; Son CG
    J Transl Med; 2020 Jul; 18(1):289. PubMed ID: 32727489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting Chronic Fatigue Syndrome versus Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Jason LA; Brown A; Evans M; Sunnquist M; Newton JL
    Fatigue; 2013 Jun; 1(3):168-183. PubMed ID: 23914329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Strand EB; Mengshoel AM; Sandvik L; Helland IB; Abraham S; Nes LS
    Scand J Pain; 2019 Jan; 19(1):61-72. PubMed ID: 30325738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.